In vivo proton magnetic resonance spectroscopy (1 H MRS) is a neurochemical technique used to investigate specific brain metabolites, which can expand on the structural and functional information ...

Treatment with cytotoxic and cytostatic agents in addition to surgery is the cornerstone of clinical therapy for childhood solid tumours. Alteration in tumour size, assessed by magnetic resonance ...

“Low-Risk” Prediction Rule for Pediatric Oncology Patients Presenting With Fever and Neutropenia PURPOSE: Proton magnetic resonance spectroscopic imaging (1 H-MRSI) is a noninvasive technique for ...

Proton MR spectroscopy can identify changes in the brains of people with multiple sclerosis (MS), according to a study published in Radiology. The findings could translate to earlier diagnosis and ...

Combining proton MRI with spectroscopy allows the scientists to differentiate intracellular components of the cell and signals emitted by certain biochemicals, such as choline. In the study, 15 ...

This section is focused on in vivo studies of human beings and animals in health and disease enabled by very-high-field magnetic resonance imaging and spectroscopy. Much of the material presented here ...

Researchers at Johns Hopkins have used a chemical marker detected by proton magnetic resonance spectroscopic imaging (MRSI) to successfully diagnose breast cancer. HT Image The study comprising ...

The water-soluble metabolite profile of human mesenchymal stem cells is known, but the lipid profile remains unclear. Haiyang Dai and colleagues from Shantou University Medical College used ...

WEST LAFAYETTE, Ind. — The same technology behind MRI images of injury or disease also powers nuclear magnetic resonance (NMR) spectroscopy, which is used to analyze biological molecules for research ...